These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6364477)

  • 1. Ability of neonatally induced tolerance of Ia antigens to overcome adoptive transfer of allo-Ia immunity and to erase its memory.
    Streilein JW; Strome PG; Mohler KM; Wood PJ
    Transplantation; 1984 Jan; 37(1):106-7. PubMed ID: 6364477
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens.
    Powell TJ; Streilein JW
    Transplantation; 1991 Aug; 52(2):383-6. PubMed ID: 1831305
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of alloantigen-specific cytotoxic and suppressor activities of lymphocytes by intravenous immunization of mice when donor and recipient differ in class II MHC molecule.
    Kronin VV; Anosova NG; Brondz BD; Chernysheva AD; Krivoshein YS; Popov IA
    Mikrobiol Z; 1993; 55(5):51-5. PubMed ID: 7512873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
    Hasek M; Holán V; Chutná J
    Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1505-14. PubMed ID: 7913940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Ia treatment prevents lupus-like autoimmune syndrome in mice neonatally tolerized to alloantigens.
    Kramar G; Schurmans S; Aguado T; Izui S; Del Giudice G; Lambert PH
    J Autoimmun; 1993 Feb; 6(1):27-37. PubMed ID: 8096138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in peripheral V beta 11+ T-cell populations are not predictive of allograft rejection in I-E- mice resistant to neonatal tolerance induction.
    Nassiri M; Koh M; Padmanabhan J; Viciana A; Streilein JW; Ruiz P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):368-70. PubMed ID: 8438339
    [No Abstract]   [Full Text] [Related]  

  • 10. Are histocompatibility antigens in neonatal skin grafts truly tolerogenic?
    Polácková M; Svec M; Viklický V
    Folia Biol (Praha); 1979; 25(2):95-100. PubMed ID: 378720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the capacity of neonatal skin grafts to induce tolerance in adult mice.
    Wachtel SS; Silvers WK
    Adv Biol Skin; 1971; 11():223-31. PubMed ID: 4950053
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split tolerance in spleen chimeras.
    Sprent J; Hurd M; Schaefer M; Heath W
    J Immunol; 1995 Feb; 154(3):1198-206. PubMed ID: 7822792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of transplantation tolerance to X-irradiation.
    Holán V; Hasek M; Chutná J
    Folia Biol (Praha); 1979; 25(2):134-6. PubMed ID: 378719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression in class II MHC tolerance is mediated by Ia-specific lymphocytes that fail to mature into allodestructive effectors.
    Streilein JW; Mohler KM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):236-7. PubMed ID: 2523129
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation tolerance: clonal deletion, active suppression, or both?
    Gruchalla RS; Streilein JW
    Transplant Proc; 1981 Mar; 13(1 Pt 1):574-7. PubMed ID: 6455802
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal suppression with anti-Ia antibody. I. Suppression of murine B lymphocyte development.
    Fultz MJ; Scher I; Finkelman FD; Kincade P; Mond JJ
    J Immunol; 1982 Sep; 129(3):992-5. PubMed ID: 6980929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic immune response to peripheral nerve transplants across major histocompatibility class-I and class-II barriers.
    Trumble TE; Gunlikson R; Parvin D
    J Orthop Res; 1994 Nov; 12(6):844-52. PubMed ID: 7983560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.